The Latest
Washington, D.C. Youth Face Barriers to HIV Prevention and Sexual Health
Young people in the nation's capital are living in the middle of some of the worst structural and systemic inequalities in America. We should be helping them out.
Initiative Amplifies Voices of Women Scientists in News Media
"I would like to dispel the notion that scientists in general are old white men in lab coats," said HIV researcher Zandrea Ambrose, Ph.D, a participant in the "500 Women Scientists" movement.
Study Shows Depressive Symptoms Associated With Detectable HIV Viral Load, but Not With Missed Visits
Adherence to HIV care visits was associated more with mental health conditions before starting antiretroviral treatment than with recent depressive symptoms, while a detectable viral load was related to such symptoms.
Novel Drugs in the Pipeline for HIV Treatment
The antiretrovial therapy pipeline includes new medications in existing drug classes as well as medications with novel mechanisms of action.
The Future of 2-Drug Regimens for People With HIV
Reducing the number of drugs in a treatment regimen lowers long-term drug exposure and potential drug toxicity or drug interactions. What can we expect in the future for two-drug regimens?
In the Golden Age of the Hep C Cure, Discount Deals Tie Doctors' Hands
Who has the power to prescribe medications? In the ongoing struggle to cure the estimated 3.2 million people living with chronic hepatitis C virus (HCV) infection in the U.S., the answer may not be who you think.